Safety and feasibility of modified duct-to-mucosa pancreaticojejunostomy during pancreatoduodenectomy: A retrospective cohort study

Table 3 Comparison results between End-to-side invagination pancreatoduodenectomy and Modified duct-to-mucosa pancreatoduodenectomy, n (%)

	End-to-side invagination pancreatoduodenectomy (n = 108)	Modified duct-to-mucosa pancreatoduodenectomy (n = 107)	P value
Age (yr)	53.6 ± 13.7	55.3 ± 12.8	0.336
Male	50 (46.3)	62 (57.9)	0.088
Pancreatic texture			0.152
Hard	51 (47.2)	61 (57.0)
Soft	57 (52.8)	46 (43.0)
Main pancreatic duct diameter			0.033a
≤ 3 mm	53 (49.1)	68 (63.6)
> 3 mm	55 (50.9)	39 (36.4)
Operative time (min)	333.2 ± 48.9	283.4 ± 54.2	< 0.0001a
Blood loss (mL)	571.4 ± 257.3	538.7 ± 195.4	0.295
Postoperative complications
Postoperative pancreatic fistula	30 (27.8)	12 (11.2)	0.002a
Grade A	20 (18.5)	7 (15.9)
Grade B	7 (6.5)	4 (3.7)
Grade C	3 (2.8)	1 (0.9)
Peritoneal infection	13 (12.0)	15 (13.9)	0.38
Intra-abdominal hemorrhage	15 (13.9)	10 (9.3)	0.299
Biliary fistula	11 (10.2)	9 (8.3)	0.654
Re-operation	3 (2.8)	1 (0.9)	0.622
Mortality	2 (1.9)	0 (0)	0.498
Length of stay (d)	16 ± 2.6	15.5 ± 2.8	0.187

^aStatistically significant.